The Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
CANTON, Conn., Sept. 15, 2025 /PRNewswire/ -- Kelyniam Global (OTC:KLYG), a maker of custom cranial implants, today announced that Terrance Kurtenbach, CFO, will present live at the Life Sciences Virtual Investor Forum hosted by VirtualInvestorConferences.com, on September 18th, 2025
kAmkDEC@?8msp%tk^DEC@?8mi $6AE6>36C `gkDFAmE9k^Am
kAmk^DFAmkDEC@?8m%x|ti kDA2? 4=2DDlQI?\49C@?Qm`_i__ ts%k^DA2?mk^Am
kAmk^DEC@?8mkDEC@?8m{x}zik^DEC@?8m k2 9C67lQ9EEADi^^6586]AC?6HDH:C6]4@>^4^=:?<^nEl_U2>Aj=l6?U2>Aj@lcd_gggb\`U2>Aj9laebce_hc`_U2>AjFl9EEADTbpTauTauHHH]G:CEF2=:?G6DE@C4@?76C6?46D]4@>TauH44Tau69Taucg`ch_cTau42E68@CJTau`cdabaTauD6AE6>36C\`gE9\=:76\D4:6?46D\G:CEF2=\:?G6DE@C\7@CF>U2>Aj2ltG6?ETraTp_s6E2:=DQ E2C86ElQ03=2?<Q C6=lQ?@7@==@HQmkDA2? DEJ=6lQE6IE\564@C2E:@?i F?56C=:?6QmtG6?Ek^DA2?m kDA2? DEJ=6lQE6IE\564@C2E:@?i F?56C=:?6Qms6E2:=Dk^DA2?mk^2mk^Am
kAmr@>A2?J >2?286>6?E H:== 36 2G2:=23=6 7@C `I` >66E:?8Di kDA2? 4=2DDlQI?\49C@?Qm$6AE6>36C `gk^DA2?m W!|X[ `h[ aa]Â !=62D6 FD6Â E96Â =:?<Â 23@G6Â 7@CÂ D4965F=:?8]k^Am
kAm%9:D H:== 36 2 =:G6[ :?E6C24E:G6 @?=:?6 6G6?E H96C6 :?G6DE@CD 2C6 :?G:E65 E@ 2D< E96 4@>A2?J BF6DE:@?D :? C62=\E:>6] x7 2EE6?566D 2C6 ?@E 23=6 E@ ;@:? E96 6G6?E =:G6 @? E96 52J @7 E96 4@?76C6?46[ 2? 2C49:G65 H6342DE H:== 2=D@ 36 >256 2G2:=23=6 27E6C E96 6G6?E]k^Am
kAmxE :D C64@>>6?565 E92E @?=:?6 :?G6DE@CD AC6\C68:DE6C 2?5 CF? E96 @?=:?6 DJDE6> 4964< E@ 6IA65:E6 A2CE:4:A2E:@? 2?5 C646:G6 6G6?E FA52E6D]k^Am
kAm{62C? >@C6 23@FE E96 6G6?E 2E k2 9C67lQ9EEADi^^6586]AC?6HDH:C6]4@>^4^=:?<^nEl_U2>Aj=l6?U2>Aj@lcd_gggb\`U2>Aj9l`bdaa_c`bdU2>AjFl9EEADTbpTauTauHHH]G:CEF2=:?G6DE@C4@?76C6?46D]4@>TauH44Tau69Taucg`ch_cTauG:CEF2=\:?G6DE@C\4@?76C6?46DU2>Aj2lHHH]G:CEF2=:?G6DE@C4@?76C6?46D]4@>]Q E2C86ElQ03=2?<Q C6=lQ?@7@==@HQmkDA2? DEJ=6lQE6IE\564@C2E:@?i F?56C=:?6QmHHHk^DA2?mkDA2? DEJ=6lQE6IE\564@C2E:@?i F?56C=:?6Qm]G:CEF2=:?G6DE@C4@?76C6?46D]4@>]k^DA2?mk^2mk^Am
kAmz6=J?:2> 92D 3@E9 D2=6D >@>6?EF> 2?5 255:E:@?2= AC@5F4E =:?6 6?92?46>6?ED E@ AC6D6?E E@ E96 4FCC6?E >2C<6E] $FC86@?D H9@ =:<6 E96 @DE6@:?E68C2E:G6 36?67:ED @7 :>A=2?ED 42? 7:?5 D:>:=2C @C 36EE6C C6DF=ED H:E9 E96 rFDE@>:K65q@?6 W9J5C@IJ2A2E:E6X :>A=2?E z6=J?:2> =:46?D65 6I4=FD:G6=J 7C@> u:?46C2>:42 $A2 @7 xE2=J] %@86E96C H:E9 E96 ~DE6@$EC:A 2?5 ~DE6@A=F8 AC@5F4E =:?6D 7C@> ~DE6@A@C6[ kDA2? 4=2DDlQI?\=@42E:@?Qm$:?82A@C6k^DA2?m[ z6=J?:2> :D H6== A@D:E:@?65 E@ 364@>6 E96 =6256C :? C686?6C2E:G6 @AE:@?D 7@C &]$] DFC86@?D]k^Am
kAmkDEC@?8mkDA2? DEJ=6lQE6IE\564@C2E:@?i F?56C=:?6Qmp3@FEk^DA2?mk^DEC@?8m kDEC@?8mkDA2? DEJ=6lQE6IE\564@C2E:@?i F?56C=:?6Qmz6=J?:2>k^Am
kAmk^DA2?mk^DEC@?8mz6=J?:2> x?4][ DA64:2=:K6D :? E96 C2A:5 AC@5F4E:@? @7 4FDE@> AC@DE96E:4D FE:=:K:?8 4@>AFE6C 2:565 56D:8? 2?5 4@>AFE6C 2:565 >2?F724EFC:?8 @7 25G2?465 >65:42= 8C256 A@=J>6CD] %96 r@>A2?J 56G6=@AD[ >2?F724EFC6D[ 2?5 5:DEC:3FE6D 4FDE@> 4C2?:2= :>A=2?ED 7@C A2E:6?ED] z6=J?:2> H@C<D 5:C64E=J H:E9 DFC86@?D[ 962=E9 DJDE6>D 2?5 A2J@CD E@ :>AC@G6 4=:?:42= 2?5 4@DE\@7\42C6 @FE4@>6D] z6=J?:2>VD H63 D:E6 255C6DDÂ :DÂ k2 9C67lQ9EEADi^^6586]AC?6HDH:C6]4@>^4^=:?<^nEl_U2>Aj=l6?U2>Aj@lcd_gggb\`U2>Aj9l`fbfdccahaU2>AjFl9EEATbpTauTauHHH]<6=J?:2>]4@>TauU2>Aj2lHHH]z6=J?:2>]4@>Q E2C86ElQ03=2?<Q C6=lQ?@7@==@HQmHHH]z6=J?:2>]4@>k^2m]k^Am
kAmpD 2 42FE:@?2CJ ?@E6 E@ :?G6DE@CD[ 46CE2:? >2EE6CD 5:D4FDD65 :? E9:D AC6DD C6=62D6 2C6 7@CH2C5\=@@<:?8 DE2E6>6?ED H:E9:? E96 >62?:?8 @7 E96 !C:G2E6 $64FC:E:6D {:E:82E:@? #67@C> p4E @7 `hhd] $F49 >2EE6CD :?G@=G6 C:D<D 2?5 F?46CE2:?E:6D E92E >2J 42FD6 24EF2= C6DF=ED E@ 5:776C >2E6C:2==J[ :?4=F5:?8 E96 7@==@H:?8i 492?86D :? 64@?@>:4 4@?5:E:@?Dj 86?6C2= 4@>A6E:E:G6 724E@CDj E96 r@>A2?JVD 23:=:EJ E@ 6I64FE6 :ED D6CG:46 2?5 AC@5F4E D2=6D A=2?Dj 492?86D :? E96 DE2EFD @7 23:=:EJ E@ >2C<6E AC@5F4EDj 2?5 E96 C:D<D 56D4C:365 7C@> E:>6 E@ E:>6 :? E96 r@>A2?JVD $tr C6A@CEDk^Am
kAmkDEC@?8mp3@FE ':CEF2= x?G6DE@C r@?76C6?46D®k^Am
kAmk^DEC@?8m':CEF2= x?G6DE@C r@?76C6?46D W'xrX :D E96 =625:?8 AC@AC:6E2CJ :?G6DE@C 4@?76C6?46 D6C:6D E92E AC@G:56D 2? :?E6C24E:G6 7@CF> 7@C AF3=:4=J EC2565 4@>A2?:6D E@ D62>=6DD=J AC6D6?E 5:C64E=J E@ :?G6DE@CD]k^Am
kAm!C@G:5:?8 2 C62=\E:>6 :?G6DE@C 6?8286>6?E D@=FE:@?[ 'xr :D DA64:7:42==J 56D:8?65 E@ @776C 4@>A2?:6D >@C6 677:4:6?E :?G6DE@C 2446DD]Â #6A=:42E:?8 E96 4@>A@?6?ED @7 2? @?\D:E6 :?G6DE@C 4@?76C6?46[ 'xr @776CD 4@>A2?:6D 6?92?465 42A23:=:E:6D E@ 4@??64E H:E9 :?G6DE@CD[ D4965F=6 E2C86E65 @?6\@?\@?6 >66E:?8D 2?5 6?92?46 E96:C AC6D6?E2E:@?D H:E9 5J?2>:4 G:56@ 4@?E6?E]Â p446=6C2E:?8 E96 ?6IE =6G6= @7 :?G6DE@C 6?8286>6?E[ ':CEF2= x?G6DE@C r@?76C6?46D 56=:G6CD =625:?8 :?G6DE@C 4@>>F?:42E:@?D E@ 2 8=@32= ?6EH@C< @7 C6E2:= 2?5 :?DE:EFE:@?2= :?G6DE@CD]k^Am
kA :5lQ!&#{Qmk:>8 E:E=6lQr:D:@?Q H:5E9lQ`aQ 96:89ElQ`aQ 2=ElQr:D:@?Q DC4lQ9EEADi^^6586]AC?6HDH:C6]4@>^4^:>8^72G:4@?]A?8nD?l}*fb_beU2>AjD5la_ad\_h\`dQ ^m ':6H @C:8:?2= 4@?E6?Eik2 :5lQ!#}&#{Q C6=lQ?@7@==@HQ 9C67lQ9EEADi^^HHH]AC?6HDH:C6]4@>^?6HD\C6=62D6D^<6=J?:2>\8=@32=\:?4\E@\AC6D6?E\2E\E96\=:76\D4:6?46D\G:CEF2=\:?G6DE@C\7@CF>\D6AE6>36C\`gE9\b_adddgf_]9E>=Q E2C86ElQ03=2?<Qm9EEADi^^HHH]AC?6HDH:C6]4@>^?6HD\C6=62D6D^<6=J?:2>\8=@32=\:?4\E@\AC6D6?E\2E\E96\=:76\D4:6?46D\G:CEF2=\:?G6DE@C\7@CF>\D6AE6>36C\`gE9\b_adddgf_]9E>=k^2mk^Am
kAm$~&#rt z6=J?:2> v=@32= x?4k^Am
kAmk:>8 2=ElQQ DC4lQ9EEADi^^CE]AC?6HDH:C6]4@>^CE]8:7n}6HDxE6>x5l}*fb_beU2>Aj%C2?D>:DD:@?0x5la_ad_h`d___`!#0}t($0&$!#00000}*fb_beU2>Ajs2E6x5la_ad_h`dQ DEJ=6lQ3@C56Ci_AIj H:5E9i`AIj 96:89Ei`AIjQ ^mk^Am
(0) comments
Welcome to the discussion.
Log In
Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.